Laboratory: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Fmacary (talk | contribs)
Fmacary (talk | contribs)
Line 22: Line 22:
| colspan="4" align="center" style="background:#dddddd" | '''2008'''
| colspan="4" align="center" style="background:#dddddd" | '''2008'''
|-
|-
|
| June
| IHE Laboratory goes wiki
| Prepare final text for the 6 pfofiles LTW, LDA, LPOCT, LBL, LCSD, XD-LAB<BR> approve inter-lab workflow (ILW) supplement proposal
| Q1
| June 23-25
| <Please register>
| Face to face meeting New York
|-
|-
| Q1-Q2
| July
| Write proposals for future supplements<BR>
| Cross domain review of LAB TF vol 3 (XD-LAB specifications)
- Lab to Lab messaging related to subcontracting<BR>
| up to August 6
- Dealing with images with thest results<BR>
| calls +join meeting with ITI & PCC
- Attaching a lab report(pdf, CDA?) to a results message
| before next Face To Face meeting
| By E-mail
|-
|-
| Q1-Q2
| August
| Integrate Change Proposals<BR>
| Publish LAB TF 2.1 Final Text
- Vol 1: Extend scope to non human subject, add Public Health lab use case<BR>
| August 8
- Vol 2: upgrade to HL7 v2.5.1, fully detail SPM, ORC, OBX, microbio WF<BR>
| emails & calls
- Vol 3: Harmonize XD-LAB with PCC content modules
| before next Face To Face meeting
| By E-mail
|-
|-
| June 23-25
| Sept-Oct
| Finalize LAB TF 2.1 Final Text - Progress on the 3 supplements
| Collect more supplement proposals
| June 23-25
| Oct 31
| New York (F2F hosted by IBM)
| emails
|-
|-
| December
| December
| Build the 3 supplements
| Final selection of supplements + continue building ILW
| around 10 Dec.
| Dec 15-17
| Japan (F2F)
| Face to face meeting, Paris
|-
|-
| colspan="4" align="center" style="background:#dddddd" | '''2009'''
| colspan="4" align="center" style="background:#dddddd" | '''2009'''
|-
|-
| ...
| January - March
| Publish the supplements for trial implementation
| Build the supplements
| ...
| March 31
| ...
| email
|-
| April
| Publish the supplements for public comment. <BR>Public comment period lasts until May 4.
| Apr 3 to May 4
| email + forum
|-
| May
| Resolve comments on  supplements
| May 8-10
| face to face meeting, Kyoto
|-
| June
| Public Supplements for Trial Implementation
| June 5
| email
|-
|-
| colspan="4" align="center" style="background:#dddddd" | '''Connectathon'''
| colspan="4" align="center" style="background:#dddddd" | '''Connectathon'''

Revision as of 12:14, 2 September 2008

IHE Laboratory addresses information sharing and workflow related to in vitro diagnostic testing in clinical laboratories as well as on the point of care.

IHE Laboratory is sponsored by the Groupement pour la Modernisation du Système d'Information Hospitalier (GMSIH), the Société d'Informatique de Laboratoire (SFIL), IHE-J, and JAHIS and manages the Laboratory Profiles and the Laboratory Technical Framework.

There are two committees:


Timeline : 2008-2009 Development Cycle

The Timeline shows the main milestones of each annual development cycle, the Timeframe when they are typically expected to happen, and the actual date/time/location they have been Scheduled for this year. Specific meetings and their agendas and minutes are generally listed on the Laboratory Planning Committee and Laboratory Technical Committee pages. The consolidated timeline of all IHE domains can be seen on Domain_Milestone_Dates

Timeframe Activity Scheduled Location
2008
June Prepare final text for the 6 pfofiles LTW, LDA, LPOCT, LBL, LCSD, XD-LAB
approve inter-lab workflow (ILW) supplement proposal
June 23-25 Face to face meeting New York
July Cross domain review of LAB TF vol 3 (XD-LAB specifications) up to August 6 calls +join meeting with ITI & PCC
August Publish LAB TF 2.1 Final Text August 8 emails & calls
Sept-Oct Collect more supplement proposals Oct 31 emails
December Final selection of supplements + continue building ILW Dec 15-17 Face to face meeting, Paris
2009
January - March Build the supplements March 31 email
April Publish the supplements for public comment.
Public comment period lasts until May 4.
Apr 3 to May 4 email + forum
May Resolve comments on supplements May 8-10 face to face meeting, Kyoto
June Public Supplements for Trial Implementation June 5 email
Connectathon

See also meeting minutes of the regular Face to Face meetings.

Roadmap

See table with development cycle for more details.

Current Activity

The Laboratory Committee is preparing the 2.1 Final Text version of the LAB Technical Framework, providing precise description of microbiology messaging in LTW profile, in line (for the result part) with the "Lab result to ambulatory EHR" implementation guide produced by HL7 LAB SIG, and refining the content of a microbio order placing message, with detailed specimen collection data. On the other hand, this Final Text version will integrate the Public Health Lab Report initially drafted in PCC domain, and in doing so, shall describe XD-LAB CDA lab report with more content modules, following the layout refined by the PCC technical committee.
This Final Text revision shall also process and integrate as much as possible new accepted CPs coming from the 2008 connectathons in NA, Europe and Japan.
The committee is also drafting three new supplements, as mentioned in the table above.
Contact the Technical Committee if you would like to participate, or watch for Public Comment supplement drafts in mid-Year 2008.

Profile Selection

These Brief Profile Proposals were submitted for the 2006-2007 Development Cycle:

  • <links to proposals>
  • ...

These Detailed Profile Proposals were short-listed and evaluated by the Technical Committee

  • ...

These items were selected by the Planning Committee for this Cycle:

  • <links>
  • ...
  • TF Maintenance

Demonstrations & Presentations

The following are recent and upcoming public presentations and demonstrations about IHE Lab.

Date Location Event Details
2008.05.27-30 Paris, France HIT 2008 IHE Demonstration

Supporters and Endorsements

IHE Laboratory is supported or endorsed by the following organizations:

See Also

Committees

Mailing Lists


This page is based on the Domain Template.